Improving memory function in people with Parkinson's disease-related cognitive decline
Official title: Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms
Funded at Washington University · NIH-10886048 · Data updated 2026-11-12
This study is all about helping people with Parkinson's disease who are having trouble remembering daily tasks by teaching them new strategies to manage their activities better, so they can enjoy life more and possibly slow down memory issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 15, 2020 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $439,290 |
| NIH project number | 5R01AG065214-05 |
| Project ID | NIH-10886048 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are experiencing cognitive decline.
✕Less likely to help
Patients who do not have Parkinson's disease or those with advanced dementia may not benefit from this research.
What this research studies
This research focuses on helping individuals with Parkinson's disease who are experiencing cognitive decline, particularly in their ability to remember to perform tasks. The approach involves teaching patients specific strategies to manage their daily activities despite memory challenges, rather than relying on traditional repetitive practice methods. By using strategy training, the goal is to enhance daily functioning and potentially delay the progression of cognitive impairment associated with Parkinson's disease dementia. This innovative method aims to provide practical tools that patients can apply in their everyday lives.
Why it matters
Potential benefit: If successful, this research could help patients maintain their independence and improve their quality of life by enhancing their memory and daily functioning.
How similar studies have gone: While strategy training has been effective in cognitive rehabilitation for brain injury and stroke, its application to Parkinson's disease dementia is a novel approach that has not been extensively tested.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Foster, Erin — Washington University
- Study coordinator: Foster, Erin
Related research
Other NIH-funded projects on the same topics.
-
Improving memory function in people with Parkinson's disease
This study is all about helping people with Parkinson's disease who are having trouble with memory and daily tasks by teaching them practical tips they can use in their everyday lives to feel more confident and improve their quality of life.
-
Metacognitive Strategy Help for Parkinson’s-Related Thinking Difficulties
Aimed at people with Parkinson’s disease who have thinking and memory challenges, this project tests a practical, everyday strategy approach to help with daily tasks and improve quality of life.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
NGF Metabolism as a biomarker for cognitive decline in familial Alzheimer's disease
Researchers are studying whether patterns in nerve growth factor pathways in blood and CSF can signal early, preclinical stages of Alzheimer's in people with genetic risk.
-
NGF metabolism as an early biomarker for cognitive decline in familial Alzheimer's disease
This project tests whether NGF pathway proteins in blood and CSF can signal early, preclinical changes in people with familial Alzheimer’s disease.
-
NGF Metabolic Dysfunction as a Marker of Cognitive Decline in Autosomal Dominant Alzheimer's Disease
This project looks at nerve growth factor pathways in people with a genetic form of Alzheimer's to see if blood and spinal fluid markers can identify early brain changes before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.